USD
+$0.00
(+0.00%
)At Close (As of Sep 8, 2025)
$5.11B
Market Cap
84.76
P/E Ratio
0.38
EPS
$46.48
52 Week High
$21.16
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $291M |
Total Revenue | $329M |
Cost Of Revenue | $38M |
Costof Goods And Services Sold | $38M |
Operating Income | $42M |
Selling General And Administrative | $154M |
Research And Development | $94M |
Operating Expenses | $249M |
Investment Income Net | - |
Net Interest Income | -$24M |
Interest Income | - |
Interest Expense | $24M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $280K |
Income Before Tax | $26M |
Income Tax Expense | $2.2M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $23M |
Comprehensive Income Net Of Tax | - |
Ebit | $50M |
Ebitda | $50M |
Net Income | $23M |
Field | Value (USD) |
---|---|
Total Assets | $578M |
Total Current Assets | $566M |
Cash And Cash Equivalents At Carrying Value | $180M |
Cash And Short Term Investments | $180M |
Inventory | $110M |
Current Net Receivables | $129M |
Total Non Current Assets | $11M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | $799K |
Investments | - |
Long Term Investments | $808K |
Short Term Investments | $131M |
Other Current Assets | $16M |
Other Non Current Assets | - |
Total Liabilities | $355M |
Total Current Liabilities | $91M |
Current Accounts Payable | $58M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.8M |
Total Non Current Liabilities | $265M |
Capital Lease Obligations | $9.3M |
Long Term Debt | $244M |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $254M |
Other Current Liabilities | $18M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $222M |
Treasury Stock | - |
Retained Earnings | -$1.5B |
Common Stock | $156K |
Common Stock Shares Outstanding | $160M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$41M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $280K |
Capital Expenditures | $45K |
Change In Receivables | - |
Change In Inventory | -$67M |
Profit Loss | - |
Cashflow From Investment | -$1M |
Cashflow From Financing | $129M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$8.8M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $23M |
Field | Value (USD) |
---|---|
Gross Profit | $291M |
Total Revenue | $329M |
Cost Of Revenue | $38M |
Costof Goods And Services Sold | $38M |
Operating Income | $42M |
Selling General And Administrative | $154M |
Research And Development | $94M |
Operating Expenses | $249M |
Investment Income Net | - |
Net Interest Income | -$24M |
Interest Income | - |
Interest Expense | $24M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $280K |
Income Before Tax | $26M |
Income Tax Expense | $2.2M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $23M |
Comprehensive Income Net Of Tax | - |
Ebit | $50M |
Ebitda | $50M |
Net Income | $23M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York.